ESR1 and breast cancer: Let us start with a general BC patient cohort with clinical data containing the following attributes: age, sex, ethnic group, disease stage, estrogen receptor (ER) status, treatment history, survival outcomes, and omics data (in particular genomics and transcriptomics data).